Lymphocyte subpopulations in Sjögren's syndrome are distinct in anti-SSA-positive patients and related to disease activity.
Filipe BarcelosCatarina Gregório MartinsNathalie MadeiraMiguel Ângelo-DiasJoana CardigosNuno AlvesJosé Vaz-PattoJaime C BrancoLuís-Miguel BorregoPublished in: Clinical rheumatology (2021)
In SjS, a distinct lymphocyte subset distribution profile seems to be associated with positive anti-SSA. Moreover, the association between ESSDAI and IL-21+CD4+ and IL-21+CD8+ (follicular) T cells in SSA+SjS patients suggests the involvement of these cells in disease pathogenesis and activity, and possibly their utility for the prognosis and assessment of response to therapy. Key Points • SSA+SjS patients have a pronounced naïve/memory B cell imbalance. • SSA+SjS patients have more active disease associated with IL-21+CD4+ and IL-21+CD8+ follicular T cell expansion. • IL-21+CD4+ and IL-21+CD8+ T cell quantification may be useful for the prognosis and assessment of response to therapy.
Keyphrases
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- disease activity
- rheumatoid arthritis
- prognostic factors
- systemic lupus erythematosus
- peritoneal dialysis
- induced apoptosis
- patient reported outcomes
- oxidative stress
- peripheral blood
- mesenchymal stem cells
- endoplasmic reticulum stress
- rheumatoid arthritis patients
- smoking cessation